Prestige Consumer Healthcare (PBH) Cash from Investing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$128.6 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 1209.7% year-over-year to -$128.6 million; the TTM figure through Dec 2025 stood at -$136.9 million (down 372.46% YoY), while the FY2025 annual figure was -$17.5 million, up 13.22% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at -$128.6 million, down from -$2.9 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.3 million in Q2 2023, with the low at -$231.7 million in Q3 2021.
• The 5-year median for Cash from Investing Activities is -$3.1 million (2022), against an average of -$22.2 million.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities slumped 2455.33% in 2021, then soared 321.87% in 2023.
• Prestige Consumer Healthcare's Cash from Investing Activities stood at -$20.2 million in 2021, then jumped by 91.09% to -$1.8 million in 2022, then plunged by 149.36% to -$4.5 million in 2023, then plunged by 118.33% to -$9.8 million in 2024, then slumped by 1209.7% to -$128.6 million in 2025.
• Business Quant data shows PBH's Cash from Investing Activities at -$128.6 million in Q4 2025, -$2.9 million in Q3 2025, and -$1.9 million in Q2 2025.